KeyBanc Capital Markets adjusted its price target on Inspire Medical Systems (NYSE:INSP) shares, lowering it to $234 from $236, while maintaining an Overweight rating on the stock. The revision ...

Stifel analysts adjusted their outlook on Inspire Medical Systems (NYSE:INSP), reducing the price target to $190 from the previous $200 while maintaining a Hold rating on the stock. The revision ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...

In a report released today, Brett Fishbin from KeyBanc maintained a Buy rating on Inspire Medical Systems (INSP – Research Report), with a ...

Zepbound is typically used to treat obesity–but it can also be used to help treat sleep apnea. Dr. Adhinav Singh joined FOX59 ...

Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

Now, a new crop of buzzy non-invasive VNS gadgets promises to relieve stress, sharpen focus and improve sleep in mere minutes ...

Snoring can be hard to sleep through, whether you're the person snoring or the partner listening to it. Unfortunately, it’s not a rare affliction. According to Johns Hopkins Medicine, 45% of ...

The price is higher than Oura, but Samsung lets you trade in devices to bring the price down. Our take: The Fitbit Inspire 3 is a great sleep tracker for someone who wants to measure physical ...

Five home-testing devices for obstructive sleep apnoea hypopnoea syndrome (OSAHS), a potentially dangerous condition affecting 2.5 million adults in the UK, have been recommended for NHS use by NICE.

If you've resolved to get better sleep in 2025, allow me to recommend one product that has changed my sleep game and could change yours: sleep earbuds. ZDNET staffers conducted hands-on testing ...